Found 25 matching trials
Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males.
PHASE2The main aim of this vaccine is to prevent cervical cancer in women. Howeve...
Location
GSK Investigational Site
Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18
PHASE3Human Papilloma virus (HPV) are viruses that cause a common infection of th...
Location
GSK Investigational Site
Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects
PHASE3Infection with human papillomavirus (HPV) has been clearly established as t...
Location
GSK Investigational Site
Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine
PHASE3This protocol posting deals with objectives \& outcome measures of the exte...
Location
GSK Investigational Site
Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study
PHASE3This extension study is conducted to assess the efficacy of the GSK 580299 ...
Location
GSK Investigational Site
Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older
PHASE3This is a multicentre study in which women were planned to receive either t...
Location
GSK Investigational Site
Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years
PHASE3Human papillomavirus infection has clearly been recognized as the cause of ...
Location
GSK Investigational Site
Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women
PHASE3The study will be extended for subjects who received all three doses of vac...
Location
GSK Investigational Site
Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects
PHASE3Infection with human papillomavirus (HPV) has been clearly established as t...
Location
GSK Investigational Site
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
PHASE4Infection with human papillomavirus (HPV) has been clearly established as t...
Location
GSK Investigational Site